Mereo BioPharma Group plc
Hedge Funds Holdings
Last updated:
Mereo BioPharma Group plc‘s stocks are currently a part of 31 hedge funds’ portfolios, which represents 4.01% of the total amount of its stocks outstanding. This makes up a total of 24.19M shares of Mereo BioPharma Group plc. Compared to the previous quarter, the number fell by -60.71% or -37.38M shares fewer. As for the holding position changes, 25.81% (8) of current hedge fund investors increased the number of shares held, 25.81% (8) of current holders sold a part of the shares held, and 22.58% (7) closed the holdings completely. 4 hedge funds are new holders of Mereo BioPharma Group plc stock in Q1 2023, it is 12.9% of total holders.
Hedge funds holding Mereo BioPharma Group (Q2 2019 – Q1 2023)
| Q2 2019 | 16 |
|---|---|
| Q3 2019 | 14 |
| Q4 2019 | 11 |
| Q1 2020 | 9 |
| Q2 2020 | 21 |
| Q3 2020 | 23 |
| Q4 2020 | 45 |
| Q1 2021 | 66 |
| Q2 2021 | 69 |
| Q3 2021 | 60 |
| Q4 2021 | 69 |
| Q1 2022 | 55 |
| Q2 2022 | 59 |
| Q3 2022 | 57 |
| Q4 2022 | 59 |
| Q1 2023 | 31 |
Hedge funds changes in Mereo BioPharma Group positions (Q2 2019 – Q1 2023)
| Q2 2019 | 16 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2019 | 1 | 5 | 3 | 3 | 2 |
| Q4 2019 | 1 | 1 | 5 | 4 | 0 |
| Q1 2020 | 3 | 1 | 4 | 4 | -3 |
| Q2 2020 | 14 | 3 | 3 | 2 | -1 |
| Q3 2020 | 8 | 6 | 4 | 6 | -1 |
| Q4 2020 | 27 | 8 | 6 | 5 | -1 |
| Q1 2021 | 30 | 17 | 7 | 9 | 3 |
| Q2 2021 | 13 | 24 | 16 | 10 | 6 |
| Q3 2021 | 9 | 15 | 18 | 18 | 0 |
| Q4 2021 | 19 | 18 | 15 | 9 | 8 |
| Q1 2022 | 2 | 22 | 11 | 16 | 4 |
| Q2 2022 | 18 | 12 | 18 | 12 | -1 |
| Q3 2022 | 8 | 19 | 15 | 11 | 4 |
| Q4 2022 | 9 | 15 | 12 | 7 | 16 |
| Q1 2023 | 4 | 8 | 8 | 7 | 4 |
Hedge funds changes in Mereo BioPharma Group stock options (Q2 2019 – Q1 2023)
| Q2 2019 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 1,147,000 | 810,000 |
| Q2 2021 | 547,000 | 447,000 |
| Q3 2021 | 237,000 | 392,000 |
| Q4 2021 | 37,000 | 75,000 |
| Q1 2022 | 81,000 | 1,000 |
| Q2 2022 | 336,000 | 221,000 |
| Q3 2022 | 162,000 | 211,000 |
| Q4 2022 | 93,425 | 86,850 |
| Q1 2023 | 6,878,000 | 0 |